• Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA 2003 Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 16: 208-214. *

• Anderson JR, Goudie RB, Gray K, Stuart-Smith DA 1968 Immunological features of idiopathic Addison's disease: an antibody to cells producing steroid hormones. Clin. Exp. Immunol. 3: 107-117. *

• Ardesjo B, Hansson CM, Bruder CE, Rorsman F, Betterle C, Dumanski JP, Kampe O, Ekwall O 2008 Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases. J. Autoimmun. 30: 273-282.

• Aubourg P 2007 X-linked adrenoleukodystrophy. Ann. Endocrinol. (Paris) 68: 403-411.

• Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH 1995 Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J. Clin. Endocrinol. Metab. 80: 2112-2117. *

• Ballarini A, Lee-Kirsch MA 2007 Genetic dissection of autoimmune polyendocrine syndrome type 2: common origin of a spectrum of phenotypes. Ann. N. Y. Acad. Sci. 1110: 159-165.

• Barker JM 2006 Type 1 diabetes associated autoimmunity: natural history, genetic associations and screening. J. Clin. Endocrinol. Metab. 91: 1210-1217. *

• Barker JM, Yu J, Yu L, Wang J, Miao D, Bao F, Hoffenberg E, Nelson JC, Gottlieb PA, Rewers M, Eisenbarth GS 2005 Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care 28: 850-855. *

• Betterle C, Dalpra C, Greggio N, Volpato M, Zanchetta R 2001 Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4. Ann. Endocrinol. (Paris) 62: 193-201.

• Betterle C, Lazzarotto F, Presotto F 2004 Autoimmune polyglandular syndrome type 2: the tip of an iceberg? Clin. Exp. Immunol. 137: 225-233. *

• Betterle C, Lazzarotto F, Spadaccino AC, Basso D, Plebani M, Pedini B, Chiarelli S, Albergoni M 2006 Celiac disease in North Italian patients with autoimmune Addison's disease. Eur. J. Endocrinol. 154: 275-279. *

• Betterle C, Rossi A, Dalla Pria S, Artifoni A, Pedini B, Gavasso S, Caretto A 1993 Premature ovarian failure: autoimmunity and natural history. Clin. Endocrinol. (Oxf.) 39: 35-43.

• Betterle C, Scalici C, Pedini B, Mantero F 1989 Addison's disease: principal clinical associations and description of natural history of the disease. Ann. Ital. Med. Int. 4: 195-206.

• Betterle C, Volpato M, Pedini B, Chen S, Smith BR, Furmaniak J 1999 Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays. J. Clin. Endocrinol. Metab. 84: 618-622. *

• Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Greggio NA, Sanzari M, Tedesco F, Pedini B, Boscaro M, Presotto F 1997 I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J. Clin. Endocrinol. Metab. 82: 932-938. *

• Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Zanchetta R, Greggio NA, Pedini B, Boscaro M, Presotto F 1997 II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J. Clin. Endocrinol. Metab. 82: 939-942. *

• Betterle C, Zanchetta R 2003 Update on autoimmune polyendocrine syndromes (APS). Acta Biomed. Ateneo. Parmense. 74: 9-33.

• Biagi F, Campanella J, Soriani A, Vailati A, Corazza GR 2006 Prevalence of coeliac disease in Italian patients affected by Addison's disease. Scand. J. Gastroenterol. 41: 302-305. *

• Bilbao JR, Martin-Pagola A, Calvo B, Perez de Nanclares G, Gepv-N, Castano L 2002 Contribution of MIC-A polymorphism to type 1 diabetes mellitus in Basques. Ann. N. Y. Acad. Sci. 958: 321-324.

• Bilbao JR, Martin-Pagola A, Perez De Nanclares G, Calvo B, Vitoria JC, Vazquez F, Castano L 2003 HLA-DRB1 and MICA in autoimmunity: common associated alleles in autoimmune disorders. Ann. N. Y. Acad. Sci. 1005: 314-318.

• Bilbao JR, Martin-Pagola A, Vitoria JC, Zubillaga P, Ortiz L, Castano L 2002 HLA-DRB1 and MHC class 1 chain-related A haplotypes in Basque families with celiac disease. Tissue Antigens 60: 71-76. *

• Bizzaro N 2007 The predictive significance of autoantibodies in organ-specific autoimmune diseases. Clin. Rev. Allergy Immunol. 34: 326-331.

• Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Huseby ES, Undlien DE 2004 Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J. Clin. Endocrinol. Metab. 89: 3474-3476. *

• Boe AS, Knappskog PM, Myhre AG, Sorheim JI, Husebye ES 2002 Mutational analysis of the autoimmune regulator (AIRE) gene in sporadic autoimmune Addison's disease can reveal patients with unidentified autoimmune polyendocrine syndrome type I. Eur. J. Endocrinol. 146: 519-522. *

• Boe Wolff AS, Oftedal B, Johansson S, Bruland O, Lovas K, Meager A, Pedersen C, Husebye ES, Knappskog PM 2008 AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I. Genes Immun. 9: 130-136. *

• Boehm BO, Manfras B, Seidl S, Holzberger G, Kuhnl P, Rosak C, Schoffling K, Trucco M 1991 The HLA-DQ beta non-Asp-57 allele: a predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease. Tissue Antigens 37: 130-132.

• Borgaonkar MR, Morgan DG 1999 Primary biliary cirrhosis and type II autoimmune polyglandular syndrome. Can. J. Gastroenterol. 13: 767-770.

• Candeloro P, Voltattorni CB, Perniola R, Bertoldi M, Betterle C, Mannelli M, Giordano R, De Bellis A, Tiberti C, Laureti S, Santeusanio F, Falorni A 2007 Mapping of human autoantibody epitopes on aromatic L-amino acid decarboxylase. J. Clin. Endocrinol. Metab. 92: 1096-1105. *

• Casten CP, Towne WD 1978 Tuberculous Addison's disease and thyrotoxicosis. JAMA 239: 2014-2015.

• Cervato S, Mariniello B, Lazzarotto F, Morlin L, Zanchetta R, Radetti G, De Luca F, Valenzise M, Giordano R, Rizzo D, Giordano C, Betterle C 2008 Evaluation of the AIRE gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives. Clin. Endocrinol. (Oxf.) Jun 27 [Epub ahead of print].

• Chase K, Sargan D, Miller K, Ostrander EA, Lark KG 2006 Understanding the genetics of autoimmune disease: two loci that regulate late onset Addison's disease in Portuguese water dogs. Int. J. Immunogenet. 33: 179-184. *

• Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Rees Smith B, Furmaniak J 1996 Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J. Clin. Endocrinol. Metab. 81: 1871-1876. *

• Coco G, Dal Pra C, Presotto F, Albergoni MP, Canova C, Pedini B, Zanchetta R, Chen S, Furmaniak J, Rees Smith B, Mantero F, Betterle C 2006 Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. J. Clin. Endocrinol. Metab. 91: 1637-1645. *

• Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD 2006 Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Br. J. Dermatol. 154: 1088-1093. *

• Dal Pra C, Chen S, Betterle C, Zanchetta R, McGrath V, Furmaniak J, Rees Smith B 2004 Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase. Eur. J. Endocrinol. 150: 313-321. *

• De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A 2005 Prolactin and autoimmunity. Pituitary 8: 25-30. *

• de Carmo Silva R, Kater CE, Dib SA, Laureti S, Forini F, Cosentino A, Falorni A 2000 Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III. Eur. J. Endocrinol. 142: 187-194. *

• de Graaff LC, Smit JW, Radder JK 2007 Prevalence and clinical significance of organ-specific autoantibodies in type 1 diabetes mellitus. Neth. J. Med. 65: 235-247. *

• Degros V, Pons L, Ghulam A, Racadot A 1999 21-Hydroxylase autoantibodies as a marker of adrenal involvement in patients with autoimmune endocrinopathies. Ann. Biol. Clin. (Paris) 57: 705-709.

• Dittmar M, Kahaly GJ 2003 Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J. Clin. Endocrinol. Metab. 88: 2983-2992. *

• Djurica S, Trbojevic B, Milosevic DP, Markovic N 2005 Autoimmune thyroid disease and associated autoimmunity. Srp. Arh. Celok. Lek. 133 Suppl. 1: 16-24.

• Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, Walfish PG, Usadel KH, Badenhoop K 1997 Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J. Clin. Endocrinol. Metab. 82: 4130-4132. *

• Eason RJ, Croxson MS, Perry MC, Somerfield SD 1982 Addison's disease, adrenal autoantibodies and computerised adrenal tomography. N. Z. Med. J. 95: 569-573.

• Elfstrom P, Montgomery SM, Kampe O, Ekbom A, Ludvigsson JF 2007 Risk of primary adrenal insufficiency in patients with celiac disease. J. Clin. Endocrinol. Metab. 92: 3595-3598. *

• Falorni A, Laureti S, Nikoshkov A, Picchio ML, Hallengren B, Vandewalle CL, Gorus FK, Tortoioli C, Luthman H, Brunetti P, Santeusanio F 1997 21-Hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry. Clin. Exp. Immunol. 107: 341-346. *

• Falorni A, Laureti S, Santeusanio F 2002 Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrinol. Metab. Clin. North Am. 31: 369-389, vii.

• Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L, Heward JM, Gough SC, de Smith A, Blakemore AI, Froguel P, Owen CJ, Pearce SH, Teixeira L, Guillevin L, Graham DS, Pusey CD, Cook HT, Vyse TJ, Aitman TJ 2007 FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat. Genet. 39: 721-723. *

• Freeman M, Weetman AP 1992 T and B cell reactivity to adrenal antigens in autoimmune Addison's disease. Clin. Exp. Immunol. 88: 275-279. *

• Frigoul A, Lefranc MP 2005 MICA: standardized IMGT allele nomenclature, polymorphisms and diseases. Recent Res. Devel. Human Genet. 3: 95-145. *

• Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F, Brunetti P, Sanjeevi CB 1999 Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 84: 3701-3707. *

• Gambelunghe G, Ghaderi M, Gharizadeh B, Brozzetti A, Tortoioli C, Del Sindaco P, Sanjeevi CB, Hjelmstrom P, Sirsjo A, Nyren P, Santeusanio F, Falorni A 2004 Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease. Eur. J. Immunogenet. 31: 73-76. *

• Gambelunghe G, Kockum I, Bini V, Giorgi GD, Celi F, Betterle C, Giordano R, Libe R, Falorni A 2005 Retrovirus-like long-terminal repeat DQ-LTR13 and genetic susceptibility to type 1 diabetes and autoimmune Addison's disease. Diabetes 54: 900-905. *

• Ghaderi M, Gambelunghe G, Tortoioli C, Brozzetti A, Jatta K, Gharizadeh B, De Bellis A, Pecori Giraldi F, Terzolo M, Betterle C, Falorni A 2006 MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency. J. Clin. Endocrinol. Metab. 91: 4107-4111. *

• Gombos Z, Hermann R, Kiviniemi M, Nejentsev S, Reimand K, Fadeyev V, Peterson P, Uibo R, Ilonen J 2007 Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations. Eur. J. Endocrinol. 157: 757-761. *

• Goudie RB, McDonald E, Anderson JR, Gray K 1968 Immunological features of idiopathic Addison's disease: characterization of the adrenocortical antigens. Clin. Exp. Immunol. 3: 119-131. *

• Gurakuqi GC, Stadlbauer V, Stepan V, Warnkross H, Trauner M 2006 Addison's disease as a rare cause of chronically elevated liver enzymes. Z. Gastroenterol. 44: 179-183.

• Gustafsson J, Alimohammadi M, Ekwall O, Gebre-Medhin G, Halldin-Stenlid M, Hedstrand H, Landgren E, Nilsson T, Rorsman F, Skoldberg F, Winqvist O, Kampe O 2004 APS I - a severe autoimmune disease with endocrine and non-endocrine symptoms. Lakartidningen 101: 2096-2098, 2101-2103.

• Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kampe O, Rorsman F, Peltonen L, Ulmanen I, Partanen J 2002 AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J. Clin. Endocrinol. Metab. 87: 2568-2574. *

• Huang W, Connor E, Rosa TD, Muir A, Schatz D, Silverstein J, Crockett S, She JX, Maclaren NK 1996 Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity. J. Clin. Endocrinol. Metab. 81: 2559-2563. *

• Humbert P, Dupond JL 1988 Multiple autoimmune syndromes. Ann. Med. Interne. (Paris) 139: 159-168.

• Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK 2000 Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J. Clin. Endocrinol. Metab. 85: 4650-4656. *

• Husebye ES, Bratland E, Bredholt G, Fridkin M, Dayan M, Mozes E 2006 The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope. Endocrinology 147: 2411-2416. *

• Jackson R, McNicol AM, Farquharson M, Foulis AK 1988 Class II MHC expression in normal adrenal cortex and cortical cells in autoimmune Addison's disease. J. Pathol. 155: 113-120.

• Jaspan JB, Luo H, Ahmed B, Tenenbaum S, Voss T, Sander DM, Bollinger K, Baquet T, Garry RF 1995 Evidence for a retroviral trigger in Graves' disease. Autoimmunity 20: 135-142.

• Jennings CE, Owen CJ, Wilson V, Pearce SH 2005 No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves' disease. Clin. Endocrinol. (Oxf.) 62: 362-365. *

• Jennings CE, Owen CJ, Wilson V, Pearce SH 2005 A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population. J. Mol. Endocrinol. 34: 859-863. *

• Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA 2007 NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356: 1216-1225. *

• Jones DB, Coulson AF, Duff GW 1993 Sequence homologies between hsp60 and autoantigens. Immunol. Today 14: 115-118.

• Jones DE 2003 Addison's other disease: primary biliary cirrhosis as a model autoimmune disease. Clin. Med. 3: 351-356. *

• Kahles H, Ramos-Lopez E, Lange B, Zwermann O, Reincke M, Badenhoop K 2005 Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur. J. Endocrinol. 153: 895-899. *

• Kasperlik-Zaluska A, Czarnocka B, Czech W 1994 High prevalence of thyroid autoimmunity in idiopathic Addison's disease. Autoimmunity 18: 213-216.

• Kasperlik-Zaluska AA, Czarnocka B, Czech W, Walecki J, Makowska AM, Brzezinski J, Aniszewski J 1998 Secondary adrenal insufficiency associated with autoimmune disorders: a report of twenty-five cases. Clin. Endocrinol. (Oxf.) 49: 779-783. *

• Kasperlik-Zaluska AA, Migdalska B, Czarnocka B, Drac-Kaniewska J, Niegowska E, Czech W 1991 Association of Addison's disease with autoimmune disorders - a long-term observation of 180 patients. Postgrad. Med. J. 67: 984-987.

• Kemp EH, Ajjan RA, Husebye ES, Peterson P, Uibo R, Imrie H, Pearce SH, Watson PF, Weetman AP 1998 A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients. Clin. Endocrinol. (Oxf.) 49: 609-613. *

• Kemp EH, Ajjan RA, Waterman EA, Gawkrodger DJ, Cork MJ, Watson PF, Weetman AP 1999 Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo. Br. J. Dermatol. 140: 73-78. *

• Kemp EH, Ridgway JN, Smith KA, Watson PF, Weetman AP 2000 Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease. Clin. Endocrinol. (Oxf.) 53: 291-299. *

• Kogawa K, Kudoh J, Nagafuchi S, Ohga S, Katsuta H, Ishibashi H, Harada M, Hara T, Shimizu N 2002 Distinct clinical phenotype and immunoreactivity in Japanese siblings with autoimmune polyglandular syndrome type 1 (APS-1) associated with compound heterozygous novel AIRE gene mutations. Clin. Immunol. 103: 277-283.

• Kong MF, Lawden M, Howlett T 2008 The Addison's disease dilemma - autoimmune or ALD? Lancet 371: 1970. *

• Kopecky O, Lukesova S, Horacek J, Parizkova R 2006 Campylobacter sepsis with multiple organ failure in IgG subclass deficiency. Folia. Microbiol. (Praha.) 51: 604-608.

• Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, Spritz RA 2005 Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 18: 300-305. *

• Latinne D, Vandeput Y, De Bruyere M, Bottazzo F, Sokal G, Crabbe J 1987 Addison's disease: immunological aspects. Tissue Antigens 30: 23-24.

• Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, Harley JB 2007 The PTPN22 C1858T functional polymorphism and autoimmune diseases - a meta-analysis. Rheumatology (Oxford) 46: 49-56. *

• Lelubre C, Lheureux PE 2008 Epigastric pain as presentation of an Addisonian crisis in a patient with Schmidt syndrome. Am. J. Emerg. Med. 26: 251.e3-e4.

• Lintas C, Cappa M, Comparcola D, Nobili V, Fierabracci A 2008 An 8-year-old boy with autoimmune hepatitis and Candida onychosis as the first symptoms of autoimmune polyglandular syndrome (APS1): identification of a new homozygous mutation in the autoimmune regulator gene (AIRE). Eur. J. Pediatr. 167: 949-953.

• Lopez ER, Zwermann O, Segni M, Meyer G, Reincke M, Seissler J, Herwig J, Usadel KH, Badenhoop K 2004 A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur. J. Endocrinol. 151: 193-197. *

• Maclaren NK, Riley WJ 1986 Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome. J. Clin. Endocrinol. Metab. 62: 455-459.

• Martin Martorell P, Roep BO, Smit JW 2002 Autoimmunity in Addison's disease. Neth. J. Med. 60: 269-275. *

• Martin MM 1971 Familial Addison's disease. Birth Defects Orig. Artic. Ser. 7: 98-100.

• Martínez A, Mas A, de Las Heras V, Bartolome M, Arroyo R, Fernandez-Arquero M, de la Concha EG, Urcelay E 2007 FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity? J. Neuroimmunol. 189: 132-136.

• Meyer G, Badenhoop K 2002 Autoimmune regulator (AIRE) gene on chromosome 21: implications for autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) any more common manifestations of endocrine autoimmunity. J. Endocrinol. Invest. 25: 804-811.

• Meyer G, Donner H, Herwig J, Bohles H, Usadel KH, Badenhoop K 2001 Screening for an AIRE-1 mutation in patients with Addison's disease, type 1 diabetes, Graves' disease and Hashimoto's thyroiditis as well as in APECED syndrome. Clin. Endocrinol. (Oxf.) 54: 335-338. *

• Myhre AG, Undlien DE, Lovas K, Uhlving S, Nedrebo BG, Fougner KJ, Trovik T, Sorheim JI, Husebye ES 2002 Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features. J. Clin. Endocrinol. Metab. 87: 618-623. *

• Neuberger J 2003 Liver transplantation for cholestatic liver disease. Curr. Treat. Options Gastroenterol. 6: 113-121.

• Neufeld M, Maclaren NK, Blizzard RM 1981 Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 60: 355-362.

• Nielsen NM, Frisch M, Rostgaard K, Wohlfahrt J, Hjalgrim H, Koch-Henriksen N, Melbye M, Westergaard T 2008 Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark. Mult. Scler. 14: 823-829.

• Nielsen TD, Steenbergen C, Russell SD 2007 Nonischemic cardiomyopathy associated with autoimmune polyglandular syndrome type II. Endocr. Pract. 13: 59-62.

• Nigam R, Bhatia E, Miao D, Yu L, Brozzetti A, Eisenbarth GS, Falorni A 2003 Prevalence of adrenal antibodies in Addison's disease among north Indian Caucasians. Clin. Endocrinol. (Oxf.) 59: 593-598. *

• O'Leary C, Walsh CH, Wieneke P, O'Regan P, Buckley B, O'Halloran DJ, Ferriss JB, Quigley EM, Annis P, Shanahan F, Cronin CC 2002 Coeliac disease and autoimmune Addison's disease: a clinical pitfall. QJM 95: 79-82. *

• Obermayer-Straub P, Strassburg CP, Manns MP 2000 Autoimmune polyglandular syndrome type 1. Clin. Rev. Allergy Immunol. 18: 167-183.

• Owen CJ, Eden JA, Jennings CE, Wilson V, Cheetham TD, Pearce SH 2006 Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J. Mol. Endocrinol. 37: 97-104. *

• Owen CJ, Kelly H, Eden JA, Merriman ME, Pearce SH, Merriman TR 2007 Analysis of the Fc receptor-like 3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J. Clin. Endocrinol. Metab. 92: 1106-1111. *

• Pani MA, Seidl C, Bieda K, Seissler J, Krause M, Seifried E, Usadel KH, Badenhoop K 2002 Preliminary evidence that an endogenous retroviral long-terminal repeat (LTR13) at the HLA-DQB1 gene locus confers susceptibility to Addison's disease. Clin. Endocrinol. (Oxf.) 56: 773-777. *

• Pani MA, Seissler J, Usadel KH, Badenhoop K 2002 Vitamin D receptor genotype is associated with Addison's disease. Eur. J. Endocrinol. 147: 635-640. *

• Papadopoulos KI, Hallengren B 1990 Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease. Acta Endocrinol. (Copenh.) 122: 472-478.

• Papadopoulos KI, Hornblad Y, Liljebladh H, Hallengren B 1996 High frequency of endocrine autoimmunity in patients with sarcoidosis. Eur. J. Endocrinol. 134: 331-336.

• Papathanasiou A, Kousta E, Skarpa V, Papachileos P, Petrou V, Hadjiathanasiou C 2007 Growth hormone deficiency in a patient with autoimmune polyendocrinopathy type 2. Hormones (Athens) 6: 247-250.

• Park YS, Sanjeevi CB, Robles D, Yu L, Rewers M, Gottlieb PA, Fain P, Eisenbarth GS 2002 Additional association of intra-MHC genes, MICA and D6S273, with Addison's disease. Tissue Antigens 60: 155-163. *

• Partanen J, Peterson P, Westman P, Aranko S, Krohn K 1994 Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility. Hum. Immunol. 41: 135-140.

• Perez De Nanclares G, Bilbao JR, Calvo B, Vitoria JC, Vazquez F, Castano L 2003 5'-Insulin gene VNTR polymorphism is specific for type 1 diabetes: no association with celiac or Addison's disease. Ann. N. Y. Acad. Sci. 1005: 319-323.

• Perez de Nanclares G, Martin-Pagola A, Ramon Bilbao J, Vazquez F, Castano L 2004 No evidence of association of CTLA4 polymorphisms with Addison's disease. Autoimmunity 37: 453-456.

• Perniola R, Falorni A, Clemente MG, Forini F, Accogli E, Lobreglio G 2000 Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Eur. J. Endocrinol. 143: 497-503. *

• Peterson P, Uibo R, Krohn KJ 2000 Adrenal autoimmunity: results and developments. Trends Endocrinol. Metab. 11: 285-290. *

• Pitkanen J, Peterson P 2003 Autoimmune regulator: from loss of function to autoimmunity. Genes Immun. 4: 12-21. *

• Prazny M, Skrha J, Limanova Z, Vanickova Z, Hilgertova J, Prazna J, Jaresova M, Striz I 2005 Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control. Physiol. Res. 54: 41-48. *

• Pujol A, Ferrer I, Camps C, Metzger E, Hindelang C, Callizot N, Ruiz M, Pampols T, Giros M, Mandel JL 2004 Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum. Mol. Genet. 13: 2997-3006. *

• Queiroz MS 2008 Type 1 diabetes and autoimmune polyendocrine syndromes. Arq. Bras. Endocrinol. Metabol. 52: 198-204.

• Ramos-Lopez E, Lange B, Kahles H, Willenberg H, Meyer G, Penna-Martinez M, Reisch N, Hahner S, Seissler J, Badenhoop K 2008 Insulin gene polymorphisms in type 1 diabetes, Addison's disease and the polyglandular autoimmune syndrome type II. BMC Med. Genet. 9: 65. *

• Rashtak S, Pittelkow MR 2008 Skin involvement in systemic autoimmune diseases. Curr. Dir. Autoimmun. 10: 344-358.

• Reimand K, Perheentupa J, Link M, Krohn K, Peterson P, Uibo R 2008 Testis-expressed protein TSGA10 an auto-antigen in autoimmune polyendocrine syndrome type I. Int. Immunol. 20: 39-44.

• Robles DT, Fain PR, Gottlieb PA, Eisenbarth GS 2002 The genetics of autoimmune polyendocrine syndrome type II. Endocrinol. Metab. Clin. North Am. 31: 353-368, vi-vii.

• Rosatelli MC, Meloni A, Meloni A, Devoto M, Cao A, Scott HS, Peterson P, Heino M, Krohn KJ, Nagamine K, Kudoh J, Shimizu N, Antonarakis SE 1998 A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum. Genet. 103: 428-434. *

• Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P 2007 Role of chemokines in endocrine autoimmune diseases. Endocr. Rev. 28: 492-520. *

• Rotondi M, Falorni A, De Bellis A, Laureti S, Ferruzzi P, Romagnani P, Buonamano A, Lazzeri E, Crescioli C, Mannelli M, Santeusanio F, Bellastella A, Serio M 2005 Elevated serum interferon-gamma inducible chemokine IP-10/CXCL10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. J. Clin. Endocrinol. Metab. 90: 2357-2363. *

• Roycroft M, Fichna M, McDonald D, Owen K, Zurawek M, Gryczynska M, Januszkiewicz-Lewandowska D, Fichna P, Cordell H, Donaldson P, Nowak J, Pearce S 2008 The tryptophan 620 allele of the lymphoid tyrosine phosphatase (PTPN22 gene) predisposes to autoimmune Addison's disease. Clin. Endocrinol. (Oxf.) Aug 15 [Epub ahead of print]. *

• Sato K, Nakajima K, Imamura H, Deguchi T, Horinouchi S, Yamazaki K, Yamada E, Kanaji Y, Takano K 2002 A novel missense mutation of AIRE gene in a patient with autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy (APECED), accompanied with progressive muscular atrophy: case report and review of the literature in Japan. Endocr. J. 49: 625-633. *

• Sato U, Horikawa R, Katsumata N, Asakura Y, Kitanaka S, Tanaka T 2004 Novel compound heterozygous AIRE mutations in a Japanese patient with APECED. J. Pediatr. Endocrinol. Metab. 17: 917-921.

• Saugier-Veber P, Drouot N, Wolf LM, Kuhn JM, Frebourg T, Lefebvre H 2001 Identification of a novel mutation in the autoimmune regulator (AIRE-1) gene in a French family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Eur. J. Endocrinol. 144: 347-351. *

• Scott HS, Heino M, Peterson P, Mittaz L, Lalioti MD, Betterle C, Cohen A, Seri M, Lerone M, Romeo G, Collin P, Salo M, Metcalfe R, Weetman A, Papasavvas MP, Rossier C, Nagamine K, Kudoh J, Shimizu N, Krohn KJ, Antonarakis SE 1998 Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol. Endocrinol. 12: 1112-1119. *

• Seissler J, Schott M, Steinbrenner H, Peterson P, Scherbaum WA 1999 Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II. Exp. Clin. Endocrinol. Diabetes 107: 208-213.

• Sekiguchi Y, Hara Y, Matsuoka H, Hayashi Y, Katsumata N, Hirata Y 2007 Sibling cases of Addison's disease caused by DAX-1 gene mutations. Intern. Med. 46: 35-39. *

• Selva-O'Callaghan A, Labrador-Horrillo M, Gallardo E, Herruzo A, Grau-Junyent JM, Vilardell-Tarres M 2006 Muscle inflammation, autoimmune Addison's disease and sarcoidosis in a patient with dysferlin deficiency. Neuromuscul. Disord. 16: 208-209.

• Shaikh MG, Lewis P, Kirk JM 2004 Thyroxine unmasks Addison's disease. Acta Paediatr. 93: 1663-1665.

• Silva RC, Sallorenzo C, Kater CE, Dib SA, Falorni A 2003 Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases. Diabetes Nutr. Metab. 16: 160-168.

• Skinningsrud B, Husebye ES, Gervin K, Lovas K, Blomhoff A, Wolff AB, Kemp EH, Egeland T, Undlien DE 2008 Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur. J. Hum. Genet. 16: 977-982. *

• Skinningsrud B, Husebye ES, Pearce SH, McDonald DO, Brandal K, Boe Wolff A, Lovas K, Egeland T, Undlien DE 2008 Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J. Clin. Endocrinol. Metab. 93: 3310-3317. *

• Smans LC, Zelissen PM 2008 Partial recovery of adrenal function in a patient with autoimmune Addison's disease. J. Endocrinol. Invest. 31: 672-674.

• Soderbergh A, Myhre AG, Ekwall O, Gebre-Medhin G, Hedstrand H, Landgren E, Miettinen A, Eskelin P, Halonen M, Tuomi T, Gustafsson J, Husebye ES, Perheentupa J, Gylling M, Manns MP, Rorsman F, Kampe O, Nilsson T 2004 Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 89: 557-562. *

• Soderbergh A, Rorsman F, Halonen M, Ekwall O, Bjorses P, Kampe O, Husebye ES 2000 Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease. J. Clin. Endocrinol. Metab. 85: 460-463. *

• Soderbergh A, Winqvist O, Norheim I, Rorsman F, Husebye ES, Dolva O, Karlsson FA, Kampe O 1996 Adrenal autoantibodies and organ-specific autoimmunity in patients with Addison's disease. Clin. Endocrinol. (Oxf.) 45: 453-460.

• Spinner MW, Blizzard RM, Gibbs J, Abbey H, Childs B 1969 Familial distributions of organ specific antibodies in the blood of patients with Addison's disease and hypoparathyroidism and their relatives. Clin. Exp. Immunol. 5: 461-468. *

• Stenberg AE, Sylven L, Hedstrand H, Kampe O, Hultcrantz M 2007 Absence of autoantibodies connected to autoimmune polyendocrine syndrome type I and II and Addison's disease in girls and women with Turner syndrome. J. Negat. Results Biomed. 6: 10. *

• Sutherland A, Davies J, Owen CJ, Vaikkakara S, Walker C, Cheetham TD, James RA, Perros P, Donaldson PT, Cordell HJ, Quinton R, Pearce SH 2007 Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. J. Clin. Endocrinol. Metab. 92: 3338-3341. *

• Thomas JB, Petrovsky N, Ambler GR 2004 Addison's disease presenting in four adolescents with type 1 diabetes. Pediatr. Diabetes 5: 207-211.

• Torrejon S, Webb SM, Rodriguez-Espinosa J, Martinez de Osaba MJ, Corcoy R 2007 Long-lasting subclinical Addison's disease. Exp. Clin. Endocrinol. Diabetes 115: 530-532.

• Uibo R, Aavik E, Peterson P, Perheentupa J, Aranko S, Pelkonen R, Krohn KJ 1994 Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J. Clin. Endocrinol. Metab. 78: 323-328. *

• Vaidya B, Imrie H, Geatch DR, Perros P, Ball SG, Baylis PH, Carr D, Hurel SJ, James RA, Kelly WF, Kemp EH, Young ET, Weetman AP, Kendall-Taylor P, Pearce SH 2000 Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 85: 688-691. *

• Vaidya B, Pearce S 2004 The emerging role of the CTLA-4 gene in autoimmune endocrinopathies. Eur. J. Endocrinol. 150: 619-626. *

• Valdemarsson S, Hedner P, Low B 1981 HLA antigens in two siblings with autoimmune Addison's disease. Acta Med. Scand. 210: 517-519.

• Valenzise M, Meloni A, Betterle C, Giometto B, Autunno M, Mazzeo A, Cao A, De Luca F 2008 Chronic inflammatory demyelinating polyneuropathy as a possible novel component of autoimmune poly-endocrine-candidiasis-ectodermal dystrophy. Eur. J. Pediatr. May 7 [Epub ahead of print]. *

• Van Thiel DH, Smith WI Jr, Rabin BS, Fisher SE, Lester R 1977 A syndrome of immunoglobulin A deficiency, diabetes mellitus, malabsorption, a common HLA haplotype. Immunologic and genetic studies of forty-three family members. Ann. Intern. Med. 86: 10-19.

• Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT, Ball SG, James RA, Quinton R, Perros P, Pearce SH 2004 The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J. Clin. Endocrinol. Metab. 89: 5862-5865. *

• Vita JA, Silverberg SJ, Goland RS, Austin JH, Knowlton AI 1985 Clinical clues to the cause of Addison's disease. Am. J. Med. 78: 461-466.

• Wallaschofski H, Meyer A, Tuschy U, Lohmann T 2003 HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm. Metab. Res. 35: 120-124.

• Walter M, McDonald CG, Paty BW, Shapiro AM, Ryan EA, Senior PA 2007 Prevalence of autoimmune diseases in islet transplant candidates with severe hypoglycaemia and glycaemic lability: previously undiagnosed coeliac and autoimmune thyroid disease is identified by screening. Diabet. Med. 24: 161-165. *

• Warzee E, Legros JJ, Geenen V 2002 Autoimmune polyendocrine syndrome (APS). Rev. Med. Liege. 57: 710-714.

• Weetman AP 1995 Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity. Baillieres Clin. Endocrinol. Metab. 9: 157-174.

• Weetman AP 2005 Non-thyroid autoantibodies in autoimmune thyroid disease. Best Pract. Res. Clin. Endocrinol. Metab. 19: 17-32.

• Winqvist O, Rorsman F, Kämpe O 2000 Autoimmune adrenal insufficiency: recognition and management. BioDrugs 13: 107-114.

• Wolff AS, Erichsen MM, Meager A, Magitta NF, Myhre AG, Bollerslev J, Fougner KJ, Lima K, Knappskog PM, Husebye ES 2007 Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J. Clin. Endocrinol. Metab. 92: 595-603. *

• Wolff AS, Myhr KM, Vedeler CA, Husebye ES 2007 Fcgamma receptor polymorphisms are not associated with autoimmune Addison's disease. Scand. J. Immunol. 65: 555-558. *

• Yu L, Brewer KW, Gates S, Wu A, Wang T, Babu SR, Gottlieb PA, Freed BM, Noble J, Erlich HA, Rewers MJ, Eisenbarth GS 1999 DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J. Clin. Endocrinol. Metab. 84: 328-335. *

• Zelissen PM, Bast EJ, Croughs RJ 1995 Associated autoimmunity in Addison's disease. J. Autoimmun. 8: 121-130.

• Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, Shum A, Zamir E, Badolato R, Law A, Eisenbarth GS, Anderson MS 2007 A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1. Clin. Immunol. 125: 131-137. *

Number of references = 163

www psc-literature.org